| Detailed information |
|---|
| CancerLivER ID | 2028 |
| Biomarker | EMP1-008 |
| Biomarker Name/Symbol (given in Publication) | EMP1-008 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | Potential diagnostic and prognostic biomarker for ICC metastasis and validated on independent dataset |
| Experimental Condition | ICC v/s Normal; significantly downregulated in ICC with tumor metastasis |
| Cancer type | Cholangiocarcinoma |
| Regulation | Downregulated in ICC (with log fold change of more than 2) |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 28401021 |
| Type of Biomarker | Diagnostic and Prognostic |
| Pathway | ERBB, JAK/STAT, MAPK, VEGF and WNT signaling pathways |
| Cohort | 4 paired cancerous and adjacent non-cancerous tissues in training and 32 of ICC patients and 4 of normal subjects for validation |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Intrahepatic cholangiocarcinoma |
| Year of Publication | 2017 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |